Back

FKBP11 drives cardiomyocyte ferroptosis in HFpEF by destabilizing GPX4 via proteasomal degradation.

30 August 2026 (17:40 - 17:50)
Organised by: Logo
Congress Presentation Part of: Drivers of heart failure with preserved ejection fraction Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Zhi Li

(China)

5 More presentations in this session

Presentation thumbnail
Unmasking the supernormal: intrinsic cardiomyopathy drives poor outcomes in heart failure with supranormal ejection fraction
Doctor Y. Chen (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Time-series analysis of the chronotropic response and its association with HFpEF risk scoring and adverse events
Doctor M. Vermeiren (Leuven, BE) Professor P. Sinnaeve (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Association between LDL-C levels and outcomes in patients with heart failure with preserved ejection fraction: a real-world study
Doctor S. Jiang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials
Doctor H. Lu (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Bridging sex differences in HFpEF diagnosis: enhanced predictive performance of the H2FPEF score by incorporating BNP and stepwise E/e′
Doctor J. Weber (Duesseldorf, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Drivers of heart failure with preserved ejection fraction
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:40 CET
You may be interested in
thumbnail
Congress Presentation
Comparative immune profiling in HFpEF: cross-species insights into inflammation and mitochondrial dysfunction
1 September 2025
thumbnail
Congress Presentation
Cardioprotective Effects of Kv4.3 on Oxidative Stress in Heart Failure
28 August 2020
thumbnail
Congress Presentation
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after doxorubicin treatment
20 June 2025
thumbnail
Congress Presentation
Endoplasmic reticulum stress as a therapeutic target for the treatment of cardiac and renal damage post myocardial infarction in the context of obesity
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources